AstraZeneca Plc said its drug Tagrisso significantly lengthened the lives of some lung cancer patients when given with chemotherapy, the latest salvo in a highly competitive battle with Johnson & Johnson to offer the most potent medicine for the condition.
www.bloomberg.com
#Astras #Lung #Cancer #Combination #Boosted #Survival #Key #Study
Astra’s Lung Cancer Combination Boosted Survival in Key Study
